Galmed Pharmaceuticals Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ramat Gan, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Galmed Pharmaceuticals Ltd. has filed 364 SEC EDGAR filings since 31 Dec 2013

SEC filing history

Showing 26-50 of 364 matching filings.

Per page
25
Current page
2
6-K File 001-36345

6-K

Filing date
30 Jan 2026
Reporting date
30 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
08 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
04 Dec 2025
Reporting date
04 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
01 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
18 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
17 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88495

SCHEDULE 13G/A filing

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
29 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
28 Oct 2025
Reporting date
28 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
19 Sep 2025
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-289703

EFFECT filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282753

EFFECT filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-289703

POS AM

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-282753

POS AM

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
25 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-289703

EFFECT filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289703

424B3

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289703

UPLOAD filing

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
15 Aug 2025
Reporting date
15 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .